Solifenacin Tablets
Indicated to manage bladder instability and designed to alleviate sudden urgency symptoms.
Strengths: 5 · 10mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Vesicare
- Therapeutic class
Antimuscarinic
- Pharmacological class
Anticholinergic
- Minor side effects
dry mouth; constipation; blurred vision; nausea
- Moderate side effects
dyspepsia; urinary tract infection; dry eyes; fatigue
- Dosage forms
Film-coated tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Astellas Pharma
- Onset Time
2–4 weeks
- Duration
24 hours
- Storage instructions
Store below 25°C in the original blister pack.
- Drug interactions
ketoconazole; verapamil; other anticholinergic drugs
- Age restrictions
Not recommended for paediatric patients.
- Pregnancy and breastfeeding
Pregnancy: Potential risk, use with caution. Breastfeeding: Not recommended.
Contraindications
hypersensitivity to solifenacin; urinary retention; severe gastrointestinal conditions; myasthenia gravis; narrow-angle glaucoma
Precautions and warnings
use caution in patients with renal impairment; monitor for urinary retention; avoid driving if drowsiness occurs
Serious side effects
urinary retention — requires immediate medical attention; intestinal obstruction — requires immediate medical attention; angioedema — requires immediate medical attention
Patient summary
Indicated to manage bladder instability and designed to alleviate sudden urgency symptoms.
Mechanism of action
Solifenacin is a competitive muscarinic receptor antagonist that inhibits the action of acetylcholine on bladder smooth muscle, thereby reducing contraction and frequency.
Solifenacin Tablets
Indicated to manage bladder instability and designed to alleviate sudden urgency symptoms.
Editorial Notes
- Active ingredient(s): Solifenacin
- Listed indication(s): Overactive Bladder
Usually available as
- 60 tablets - 5 mg1258-5-mg-15016
- 60 tablets - 10 mg1258-10-mg-15021